蒲公英 - 制药技术的传播者 GMP理论的实践者

搜索
查看: 5956|回复: 10
收起左侧

[药典讨论] 微生物OOS处理

[复制链接]
发表于 2015-12-11 16:42:24 | 显示全部楼层 |阅读模式

欢迎您注册蒲公英

您需要 登录 才可以下载或查看,没有帐号?立即注册

x
如果微生物检测出现OOS,应该如何处理?在哪能找到相关参考资料,谢谢!
回复

使用道具 举报

药徒
发表于 2015-12-11 16:59:06 | 显示全部楼层
本帖最后由 xmango 于 2015-12-11 17:00 编辑

微生物超标一般不适用于普通的oos,一般叫mdd
usp有个关于这方面的专论。查了一下是这个USP<1117>专论《Best Microbiological Practice》

回复

使用道具 举报

药徒
发表于 2015-12-11 18:29:32 | 显示全部楼层
an investigation into the microbial data deviation (MDD) is required. There are generally two distinct reasons for the observation of microbial contamination that does not comply with a target or requirement: There may be either a laboratory error or laboratory environmental conditions that produced an invalid result, or the product contains a level of contamination or specific types of contaminants outside established levels or limits. In either case, laboratory management and, in most cases, the Quality Unit should be notified immediately.
A full and comprehensive evaluation of the laboratory situation surrounding the result should be undertaken. All microbiological conditions or factors that could bring about the observed condition should be fully considered, including the magnitude of the excursion compared to established limits or levels. In addition, an estimate of the variability of the assay may be required in order to determine whether the finding is significant.
The laboratory environment, the protective conditions in place for sampling, historical findings concerning the material under test, and the nature of the material, particularly with regard to microbial survival or proliferation in contact with the material, should be considered in the investigation. In addition, interviews with the laboratory analyst(s) may provide information regarding the actual conduct of the assay that can be valuable in determining the reliability of the result and in determining an appropriate course of action. If laboratory operations are identified as the cause of the nonconforming test outcome, then a corrective action plan should be developed to address the problem(s). Following the approval and implementation of the corrective action plan, the situation should be carefully monitored and the adequacy of the corrective action determined.
If assay results are invalidated on the basis of the discovery of an attributable error, this action must be documented. Laboratories also should have approved procedures for confirmatory testing (retesting), and if necessary, resampling where
回复

使用道具 举报

药徒
发表于 2015-12-12 00:27:48 | 显示全部楼层
回复

使用道具 举报

发表于 2015-12-12 11:04:01 | 显示全部楼层
学习了,多谢!
回复

使用道具 举报

发表于 2015-12-13 14:56:37 | 显示全部楼层
学习了,多谢
回复

使用道具 举报

 楼主| 发表于 2015-12-14 16:46:22 | 显示全部楼层
工作QQ 发表于 2015-12-11 18:29
an investigation into the microbial data deviation (MDD) is required. There are generally two disti ...

英语没学好
回复

使用道具 举报

发表于 2015-12-14 22:04:55 | 显示全部楼层
可以看中国药典四部附录9203最后有
回复

使用道具 举报

药徒
发表于 2015-12-16 10:20:14 | 显示全部楼层
参照FDA指南也有。

点评

文件具体名称有吗?  详情 回复 发表于 2015-12-16 12:19
回复

使用道具 举报

药徒
发表于 2015-12-16 12:19:58 | 显示全部楼层

文件具体名称有吗?
回复

使用道具 举报

药徒
发表于 2023-3-17 13:26:58 | 显示全部楼层
工作QQ 发表于 2015-12-11 18:29
an investigation into the microbial data deviation (MDD) is required. There are generally two disti ...

请问 这出出是哪里
回复

使用道具 举报

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

×发帖声明
1、本站为技术交流论坛,发帖的内容具有互动属性。您在本站发布的内容:
①在无人回复的情况下,可以通过自助删帖功能随时删除(自助删帖功能关闭期间,可以联系管理员微信:8542508 处理。)
②在有人回复和讨论的情况下,主题帖和回复内容已构成一个不可分割的整体,您将不能直接删除该帖。
2、禁止发布任何涉政、涉黄赌毒及其他违反国家相关法律、法规、及本站版规的内容,详情请参阅《蒲公英论坛总版规》。
3、您在本站发表、转载的任何作品仅代表您个人观点,不代表本站观点。不要盗用有版权要求的作品,转贴请注明来源,否则文责自负。
4、请认真阅读上述条款,您发帖即代表接受上述条款。

QQ|手机版|蒲公英|ouryao|蒲公英 ( 京ICP备14042168号-1 )  增值电信业务经营许可证编号:京B2-20243455  互联网药品信息服务资格证书编号:(京)-非经营性-2024-0033

GMT+8, 2025-2-1 21:54

Powered by Discuz! X3.4运维单位:苏州豚鼠科技有限公司

Copyright © 2001-2020, Tencent Cloud.

声明:蒲公英网站所涉及的原创文章、文字内容、视频图片及首发资料,版权归作者及蒲公英网站所有,转载要在显著位置标明来源“蒲公英”;禁止任何形式的商业用途。违反上述声明的,本站及作者将追究法律责任。
快速回复 返回顶部 返回列表